SpyGlass Pharma has randomized the first patients in its 2 registrational phase 3 clinical trials of the Bimatoprost Drug Pad-IOL System (BIM-IOL System) for the lowering of intraocular pressure (IOP) ...
SpyGlass Pharma, a late-stage biopharmaceutical company, today announced that the first patients have been randomized in two registrational Phase III clinical trials of its lead product candidate, the ...
Using neutral language with patients and thorough documentation can help mitigate your practice’s legal risks when utilizing ...
Please provide your email address to receive an email when new articles are posted on . Age-related dementia, cataract, age-related macular degeneration, glaucoma, diabetic retinopathy and hearing ...
Children with nontraumatic cataracts undergoing implantation of a secondary intraocular lens (IOL) after lensectomy are at a risk for complications including a diagnosis of glaucoma and visual axis ...
The new full visual range IOL*1 delivers exceptional distance vision2 and 14% smaller readable print size vs PanOptix3 †. 93% of patients become free from glasses at all distances.#4 ‡ TECNIS Odyssey ...
BENGALURU, India--(BUSINESS WIRE)--Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, today announced the launch of the Clareon ® Family of intraocular ...
Did you know that when your ASC facility has a Medicare patient who requests a Presbyopia-Correcting (PC) IOL lens or an Astigmatism-Correcting (AC) IOL lens (instead of a regular IOL) that there are ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results